A Phase III, Multicentre, Randomized, Parallel Group, Double Blinded and Control Group Clinical Trial to Assess the Effectiveness of Biochaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer - NA

Trial Profile

A Phase III, Multicentre, Randomized, Parallel Group, Double Blinded and Control Group Clinical Trial to Assess the Effectiveness of Biochaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer - NA

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Sep 2016

At a glance

  • Drugs Becaplermin (Primary)
  • Indications Diabetic foot ulcer
  • Focus Registrational; Therapeutic Use
  • Sponsors Virchow Group
  • Most Recent Events

    • 25 Aug 2016 According to an Adocia media release, the company has initiated a thorough review of the study to analyse the trial data.
    • 25 Aug 2016 Top-line results published in an Adocia media release.
    • 25 Aug 2016 Status changed from recruiting to completed, according to an Adocia media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top